BACKGROUND: The objective was to investigate the impact of three national blood transfusion indicators (NBTIs) specifically designed for critical care regarding the appropriate blood transfusion indications. STUDY DESIGN AND METHODS: This was a prospective, single-center study, carried out at a university hospital. A total of 1808 patients admitted to the intensive care unit (ICU) in 1 year were included. RESULTS: The study consisted of four 90-day periods (P). P1 was a control period with no intervention. P2 followed the inclusion of NBTIs into the ICU database, aimed at reinforcing NBTI knowledge. After presenting and discussing the results of P1 and P2, the early (P3) and late (P4) impacts of NBTI knowledge were evaluated. All patients who were transfused with at least 1 unit of any blood component (33.3%) were included. Thirteen percent of red blood cell transfusions (RBCTs) were given outside of NBTI protocols (13% deviation of NBTIs for RBCTs) without a significant change throughout the duration of the study. Most RBCTs (95%) were prescribed for a hemoglobin threshold of less than 90 g/L. There was a steady and significant improvement in the adherence to NBTI guidelines for platelet concentrate transfusions (PCTs) from 36% (P1) to 52% (P4; p < 0.01). In contrast, the lack of adherence to NBTI guidelines for fresh-frozen plasma transfusions (FFPTs) remained high (74%) and stable throughout the study period. The most frequent reason for inappropriate use of FFPTs or PCTs was absence of severe bleeding. CONCLUSION: The introduction of NBTI guidelines demonstrated a variable impact on the appropriateness of blood component transfusions in critically ill patients.
BACKGROUND: The objective was to investigate the impact of three national blood transfusion indicators (NBTIs) specifically designed for critical care regarding the appropriate blood transfusion indications. STUDY DESIGN AND METHODS: This was a prospective, single-center study, carried out at a university hospital. A total of 1808 patients admitted to the intensive care unit (ICU) in 1 year were included. RESULTS: The study consisted of four 90-day periods (P). P1 was a control period with no intervention. P2 followed the inclusion of NBTIs into the ICU database, aimed at reinforcing NBTI knowledge. After presenting and discussing the results of P1 and P2, the early (P3) and late (P4) impacts of NBTI knowledge were evaluated. All patients who were transfused with at least 1 unit of any blood component (33.3%) were included. Thirteen percent of red blood cell transfusions (RBCTs) were given outside of NBTI protocols (13% deviation of NBTIs for RBCTs) without a significant change throughout the duration of the study. Most RBCTs (95%) were prescribed for a hemoglobin threshold of less than 90 g/L. There was a steady and significant improvement in the adherence to NBTI guidelines for platelet concentrate transfusions (PCTs) from 36% (P1) to 52% (P4; p < 0.01). In contrast, the lack of adherence to NBTI guidelines for fresh-frozen plasma transfusions (FFPTs) remained high (74%) and stable throughout the study period. The most frequent reason for inappropriate use of FFPTs or PCTs was absence of severe bleeding. CONCLUSION: The introduction of NBTI guidelines demonstrated a variable impact on the appropriateness of blood component transfusions in critically illpatients.
Authors: Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana Journal: Blood Transfus Date: 2013-06-17 Impact factor: 3.443
Authors: Manuel Quintana Díaz; Alberto M Borobia; José A García Erce; Charbel Maroun-Eid; Sara Fabra; Antonio Carcas; Jesus Frías; Manuel Muñoz Journal: Blood Transfus Date: 2016-07-07 Impact factor: 3.443
Authors: Santiago R Leal-Noval; Manuel Muñoz-Gómez; Mercedes Jiménez-Sánchez; Aurelio Cayuela; María Leal-Romero; Antonio Puppo-Moreno; Judy Enamorado; Victoria Arellano-Orden Journal: Intensive Care Med Date: 2012-11-27 Impact factor: 17.440
Authors: Raúl Juárez-Vela; Eva María Andrés-Esteban; Vicente Gea-Caballero; Juan Luis Sánchez-González; Pilar Marcos-Neira; Ainhoa Serrano-Lázaro; Gabriel Tirado-Anglés; Juan Carlos Ruiz-Rodríguez; Ángela Durante; Iván Santolalla-Arnedo; José Antonio García-Erce; Manuel Quintana-Díaz Journal: J Clin Med Date: 2022-02-16 Impact factor: 4.241